General Medicine and Primary Care

Host: Matt Birnholz, MD

Guest: David Weisman, MD

Dr. David Weisman, neurologist with Abington Neurological Associates and Director of Abington Neurologic Association's Trial Center, talks about expert approaches to recognizing the signs and symptoms for Alzheimer's disease.

Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Matt Birnholz, MD

More than half of those seeking a diagnosis for dementia have delayed going to their doctor by at least a year, according to a survey carried out by the Alzheimer’s Society of Great Britain. Dr. Matt Birnholz reports.

Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: John Russell, MD

Guest: Howard Fillit, MD

Quality care for patients with Alzheimer's disease starts with early recognition, which enables a timely diagnosis and subsequent intervention with the best available treatment and support options. As such, understanding the broad spectrum of signs and symptoms at the earliest stages of disease is absolutely critical.

Joining host Dr. John Russell to discuss the keys to early recognition for Alzheimer's Disease is Dr. Howard Fillit, founding Executive Director and Chief Science Officer for the Alzheimer's Drug Discovery Foundation.

Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Matt Birnholz, MD

Guest: Carol Lippa, MD

Understandings of the origins and mechanisms of Alzheimer's disease are evolving constantly, opening doors to improved targets for therapeutic research. But at a time when disease-modifying therapies for advanced Alzheimer's aren't yet available, the need for early detection becomes critically important to help protect quality of life for patients.

Host Dr. Matt Birnholz welcomes Dr. Carol Lippa, Professor of Neurology & Director of the Memory Disorders Program at Drexel University College of Medicine. Dr. Lippa is a member of the Board of Directors for the Alzheimer's Association and Chair of the Delaware Valley Chapter’s Medical & Scientific Committee.

Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Matt Birnholz, MD

Guest: Douglas Scharre, MD, CMD

Dr. Douglas Scharre, Professor of Clinical Neurology and Psychiatry and Director of the Center for Cognitive and Memory Disorders at The Ohio State University Wexner Medical Center, describes updated perspectives and understandings on the pathophysiology for Alzheimer's disease.

Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Jennifer Caudle, DO

Guest: Douglas Scharre, MD, CMD

Cognitive assessment tools and detection tests for Alzheimer's disease are mutually designed to identify signs of cognitive impairment that are sometimes too subtle to catch by astute clinicians or even patients themselves. But what methods are available to help detect Alzheimer's as early as possible, and how do they impact quality of life for patients throughout the disease progression?

Host Dr. Jennifer Caudle welcomes Dr. Douglas Scharre, Professor of Clinical Neurology and Psychiatry and Director of the Center for Cognitive and Memory Disorders at The Ohio State University Wexner Medical Center.

Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Matt Birnholz, MD

Guest: Douglas Scharre, MD, CMD

Dr. Douglas Scharre, Professor of Clinical Neurology and Psychiatry with the Center for Cognitive and Memory Disorder at The Ohio State University Wexner Medical Center, speaks to the methods used for early detection of Alzheimer’s Disease, and their respective advantages vs costs in clinical practice.

Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Matt Birnholz, MD

Guest: Marwan Noel Sabbagh, MD, FAAN, FANA

Dr. Marwan Sabbagh, Professor of Neurology and Chief of the Memory Disorders Division at Barrow Neurological Institute, describes some of his key priorities for the current and future state of Alzheimer’s care.

Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Alan S. Brown, MD, FACC, FAHA, FNLA

Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dave Dixon, PharmD, Clinical Pharmacist and Associate Professor of Pharmacology at Virginia Commonwealth University School of Pharmacy. Dr. Dixon is also a Board Certified Pharmacotherapy Specialist, Clinical Lipid Specialist, and Fellow of the National Lipid Association. He serves as a Regional Representative for the Southeast Chapter of NLA and on the Journal of Clinical Lipidology Editorial Board.

Dr. Dixon discusses guidelines for treating hypertriglyceridemia, effective therapies for reducing triglyceride levels, and emerging lipid-lowering therapies in development.

Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG

Many menopausal and perimenopausal women are faced with the decision of whether synthetic or bioidentical hormone therapy is the best option for them. There are many pros and cons for each, but questions surface from patients and clinicians alike on comparative safety and efficacy profiles.

Host Dr. Renee Allen welcomes Dr. Jocelyn Slaughter-Moore, a board-certified practicing OB/GYN at Heras Healthcare for Women. They talk about the differences between bioidentical and synthetic hormones, and whether bioidentical hormone therapy is a safe option for women.